Search results for "FARMACOTERAPIA"

showing 10 items of 23 documents

The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma …

2021

Inhibidor de KIF11; Terapias dirigidas; Metástasis Inhibidor de KIF11; Teràpies dirigides; Metàstasi KIF11 inhibitor; Targeted therapies; Metastasis In summary, our study provides a rationale for the future therapeutic integration in clinical trials of 4SC-205, an structurally distinct oral KIF11 inhibitor that shows potent antitumor activity in multiple preclinical neuroblastoma models and sensitizes neuroblastoma cells to standard chemotherapy and specific neuroblastoma-targeted therapies. The financial support for this research was provided by Instituto de Salud Calos III (PI20/00530 to Miguel F. Segura; PI20/01107 to Rosa Noguera; PI17/02248 and CPII18/00027 to Anna Santamaria; PI19/013…

Medicine (General)Neuroblastoma - Tractament:neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::neoplasias neuroepiteliales::tumores neuroectodérmicos primitivos::tumores neuroectodérmicos primitivos periféricos::neuroblastoma [ENFERMEDADES]Metastatic neuroblastomaMedicació oralMedicaments antineoplàstics - Ús terapèutic:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Medicine (miscellaneous)Administration OralKinesinsAntineoplastic Agents:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Letter to Editor:Neoplasms::Neoplasms by Histologic Type::Neoplasms Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms Neuroepithelial::Neuroectodermal Tumors Primitive::Neuroectodermal Tumors Primitive Peripheral::Neuroblastoma [DISEASES]MiceNeuroblastomaR5-920Cell Line Tumor:terapéutica::farmacoterapia::vías de administración de medicamentos::administración oral [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]MedicineAnimalsHumansAntitumor activityPrimary (chemistry)business.industry:acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS]Disease Models Animal:Therapeutics::Drug Therapy::Drug Administration Routes::Administration Oral [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Cancer researchMolecular Medicine:Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS]businessClinical and Translational Medicine
researchProduct

The debate on rare diseases : a look at media response

2015

Este artículo se encuentra disponible en la siguiente URL: https://ojs.uv.es/index.php/Metode/article/view/7188/7809 Este monográfico lleva por título "Science grid : the public understanding of science". Rare diseases (RDs) are those that affect fewer than five people in every 10,000. There are around 7,000 RDs, they are difficult to diagnose and very few have a treatment. This article explores how the media report on the arguments and counter-arguments regarding the access to drugs for these pathologies, with critical discourse analysis for the case of Duchenne muscular dystrophy. We concluded that, in times of crisis, the debate polarises around economic arguments (the price of drugs), r…

Medios de comunicación social.MultidisciplinaryHistory and Philosophy of ScienceMass media.Medicamentos - Crítica y objeción.Enfermedades raras - Discursos políticos.Duchenne Muscular Distrophy - Chemotherapy.Rare diseases - Political speeches.Duchenne Distrofia muscular de - Farmacoterapia.Drugs - Criticism and objection.humanitieshealth care economics and organizations
researchProduct

Biological Profiling of Semisynthetic C19-Functionalized Ferruginol and Sugiol Analogues

2021

[EN] The abietane-type diterpenoids are significant bioactive compounds exhibiting a varied range of pharmacological properties. In this study, the first synthesis and biological investigation of the new abietane-diterpenoid (+)-4-epi-liquiditerpenoid acid (8a) together with several of its analogs are reported. The compounds were generated from the readily available methyl callitrisate (7), which was obtained from callitrisic acid present in Moroccan Sandarac resin. A biological evaluation was conducted to determine the effects of the different functional groups present in these molecules, providing basic structure-activity relationship (SAR) elements. In particular, the ferruginol and sugi…

Microbiology (medical)Pharmacology.KetoneStereochemistryCarboxylic acidFarmacología.Antiproliferative activity01 natural sciencesBiochemistryMicrobiologyArticleAntimalarial activityHeLachemistry.chemical_compoundDiterpenoidMoiety03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsAbietanechemistry.chemical_classificationMalaria - Chemotherapy.biology010405 organic chemistryChemistrylcsh:RM1-950Sandaracbiology.organism_classificationGABA<sub>A</sub> receptor modulatorsTerpenoidCallitrisic acid0104 chemical sciencesFerruginol010404 medicinal & biomolecular chemistrylcsh:Therapeutics. PharmacologyInfectious DiseasesPaludismo - Farmacoterapia.AbietaneGABAA receptor modulators
researchProduct

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

2021

Anàlisi de seqüències d'ADN; Subtipus PAM50; Genètica molecular Análisis de secuencias de ADN; Subtipo PAM50; Genética molecular DNA sequence analyses; PAM50 subtype; Molecular genetic Background: The SOLTI-1301 AGATA study aimed to assess the feasibility of a multi-institutional molecular screening program to better characterize the genomic landscape of advanced breast cancer (ABC) and to facilitate patient access to matched-targeted therapies in Spain. Methods: DNA sequencing of 74 cancer-related genes was performed using FFPE tumor samples in three different laboratories with three different gene panels. A multidisciplinary advisory board prospectively recommended potential targeted trea…

OncologyCancer ResearchDNA Alterationmedicine.medical_specialtymolecular targeted therapyAdvanced breast:Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES]Cancer therapy:terapéutica::farmacoterapia::terapia molecular selectiva [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]:Therapeutics::Drug Therapy::Molecular Targeted Therapy [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Breast cancerbreast cancerInternal medicineGene panelmolecular geneticmedicineDNA sequence analysesRC254-282Original ResearchFarmacologia molecular:neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES]:Natural Science Disciplines::Biological Science Disciplines::Biology::Computational Biology::Genomics [DISCIPLINES AND OCCUPATIONS]Molecular screeningbusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOncologyMama - Càncer - Tractament:disciplinas de las ciencias naturales::disciplinas de las ciencias biológicas::biología::biología computacional::genómica [DISCIPLINAS Y OCUPACIONES]Mama - Càncer - Aspectes molecularsPAM50 subtypebusiness
researchProduct

1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00054/full En este artículo científico participan los siguientes autores: Mario Amore, Guido Di Sciascio, Radu Ioan Florea, Marina Garriga, Gabriel Gonzalez, Kai G. Kahl, Per-Axel Karlsson, Jens Kuhn, Maria Margariti, Bruno Pacciardi, Konstantinos Papageorgiou, Maurizio Pompili, Fabrice Rivollier, Ángel Royuela, Gemma Safont, Joachim Scharfetter, Bo Skagen, Kazuhiro Tajima-Pozo y Pierre Vidailhet. Agitation is a heterogeneous concept without a uniformly accepted definition, however, it is generally considered as a state of cognitive and motor hype…

Schizophrenia - Treatment.Psychomotor agitationlcsh:RC435-571media_common.quotation_subjectPsychomotor disorders - Treatment.ReviewMotor HyperactivityPsicosis maníaco depresiva - Tratamiento.Esquizofrenia - Farmacoterapia.Psicomotricidad - Trastornos - Tratamiento.03 medical and health sciences0302 clinical medicinePromotion (rank)Bipolar disorder Clinical practice Management Psychomotor agitation Schizophrenia Psychiatry and Mental HealthNursinglcsh:Psychiatrymedicinebipolar disorder; clinical practice; management; psychomotor agitation; schizophreniaManic-depressive illness030212 general & internal medicineManic-Depressive illness - Treatment.media_commonPsychiatrybipolar disorderProtocol (science)Psicosis maníaco depresiva - Farmacoterapia.Trastorn bipolarHealth professionalsCognitionManic-Depressive illnes - Chemotherapy.clinical practice030227 psychiatryschizophreniaClinical PracticeSchizophrenia - Chemotherapy.Psychiatry and Mental healthpsychomotor agitationSchizophreniaEsquizofrèniaEsquizofrenia - Tratamiento.medicine.symptomEmotional arousalPsychologymanagement
researchProduct

L'approccio integrato antipsicotici-psicoterapia nel trattamento del disturbo Borderline di personalità

2009

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.disturbo di personalità borderline psicoterapia farmacoterapiaSettore MED/25 - Psichiatria
researchProduct

MALNUTRIZIONE E FRAGILITÀ NELL’ANZIANO: UN CASO COMPLESSO DI MULTIMORBILITÀ E COMORBILITÀ

2016

La malnutrizione è un problema di rilevante importanza nell’anziano. Numerosi studi hanno dimostrato che la prevalenza della malnutrizione è compresa tra il 20 e il 60% nei pazienti anziani al momento dell’ammissione in un reparto ospedaliero e tra il 30 e il 50% nei pazienti che accedono alle nursing-home; alcuni studi hanno stimato un dato di prevalenza di malnutrizione pari all’85% nei pazienti anziani confinati in casa, ospedalizzati o istituzionalizzati. Nell’anziano lo stato di nutrizione influenza notevolmente l’evoluzione del quadro clinico e condiziona l’esito dei trattamenti e dei programmi di riabilitazione. Il cambiamento più frequente delle abitudini alimentari dell’anziano è r…

Settore MED/09 - Medicina Internamalnutrizione invecchiamento fragilità polifarmacoterapia comorbilità sarcopenia
researchProduct

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) …

2017

Background HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were assessment of efficacy and safety of simeprevir plus PR in treatment-naïve patients with HCV GT4 treated for 12 weeks. Primary efficacy outcome was sustained virologic response 12 weeks post-treatment (SVR12). Additional objectives included investigation of potential associations of rapid virologic response and baseline factors with SVR12. Methods This multicentre, open-label, single-arm study (NCT01846832) evaluated efficacy and safety of simepre…

SimeprevirMalePsychologie appliquéeFetge - MalaltiesHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycols0302 clinical medicinelcsh:Science61 - MedicinaLiver DiseasesSciences bio-médicales et agricolesCirrhosisInterferonLiver Fibrosis030211 gastroenterology & hepatologyDrug Therapy CombinationViral loadBiologieHumanmedicine.medical_specialtyCiències multidisciplinàriesGenotypeSaudi ArabiaAlpha interferon:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Gastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesHumansAgedMedicine and health sciencesHepaciviruFlavivirusesInterleukinslcsh:ROrganismsInterleukinmedicine.diseaseRegimen:Digestive System Diseases::Liver Diseases [DISEASES]chemistryImmunologylcsh:QMedicaments - AdministracióDevelopmental BiologyRNA viruseslcsh:Medicinemedicine.disease_cause:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Geographical Locationschemistry.chemical_compoundSimeprevirHospital Universitari Vall d’Hebron030212 general & internal medicinePathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CRecombinant ProteinMedical microbiologyMiddle AgedViral LoadHepatitis CRecombinant Proteins:enfermedades del sistema digestivo::enfermedades hepáticas [ENFERMEDADES]EuropeResearch DesignVirusesFemalePathogensResearch ArticleAdultAsiaAdolescentClinical Research DesignHepatitis C virusResearch and Analysis MethodsYoung AdultInternal medicineRibavirinmedicineddc:610Rapid Virologic ResponseAntiviral AgentBiology and life sciencesbusiness.industryRibavirinViral pathogensInterferon-alphaFibrosisHepatitis virusesMicrobial pathogensPeople and PlacesAdverse EventsInterferonsbusinessPLoS ONE
researchProduct

Impacto de un “programa interdisciplinar de mejora de la calidad de la farmacoterapia y seguridad del paciente mayor polimedicado” en un Hospital de …

2018

Objetivo: Evaluar el impacto de un “programa interdisciplinar de mejora de calidad de farmacoterapia y la seguridad del paciente mayor polimedicado” realizado en un hospital de atención a crónicos y media-larga estancia (HACLE) en términos clínicos, de adecuación de la prescripción y humanísticos. Métodos: Estudio de intervención longitudinal prospectivo, de 10 meses de duración (Octubre/2013-Julio/2014) realizado en Área Médica Integral del Hospital Pare Jofré. Se incluyeron pacientes mayores (70 o más años), polimedicados (5 o más medicamentos) que no estuvieran en situación de últimos días. En el programa, el farmacéutico integrado en el equipo interdisciplinar participó en el seguimient…

adecuaciónfarmacoterapiapolimedicacióncalidadUNESCO::CIENCIAS MÉDICAS ::Farmacología ::Otrassatisfacciónpaciente mayorproblema relacionado con medicamentoseguridad:CIENCIAS MÉDICAS ::Farmacología ::Otras [UNESCO]HACLEUNESCO::CIENCIAS MÉDICAS ::Farmacología ::Evaluación de medicamentos:CIENCIAS MÉDICAS ::Farmacología ::Evaluación de medicamentos [UNESCO]
researchProduct

La valutazione del grado di insight in pazienti schizofrenici in trattamento con antipsicotici atipici inseriti in un gruppo riabilitativo

2010

insight farmacoterapia aderenza
researchProduct